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Abstract
Background: Avian infectious bronchitis (IB) is one of the most serious diseases of economic importance in
chickens; it is caused by the avian infectious coronavirus (IBV). Information remains limited about the comparative
protein expression profiles of chicken embryonic tissues in response to IBV infection in ovo. In this study, we
analyzed the changes of protein expression in trachea and kidney tissues from chicken embryos, following IBV
infection in ovo, using two-dimensional gel electrophoresis (2-DE) coupled with matrix-assisted laser desorption/
ionization time-of-flight tandem mass spectrometry (MALDI-TOF-TOF MS).
Results: 17 differentially expressed proteins from tracheal tissues and 19 differentially expressed proteins from kidney
tissues were identified. These proteins mostly related to the cytoskeleton, binding of calcium ions, the stress response,
anti-oxidative, and macromolecular metabolism. Some of these altered proteins were confirmed further at the mRNA
level using real-time RT-PCR. Moreover, western blotting analysis further confirmed the changes of annexin A5 and HSPB1
during IBV infection.
Conclusions: To the best of our knowledge, we have performed the first analysis of the proteomic changes in
chicken embryonic trachea and kidney tissues during IBV infection in ovo. The data obtained should facilitate a
better understanding of the pathogenesis of IBV infection.
Background
Avian infectious bronchitis (IB) is one of the most serious
diseases of chickens. It is of economic importance in the
poultry industry worldwide and is associated with respira-
tory disease, reduction in weight gain, poor egg production
and quality, and decreased feed conversion efficiency.
Its etiologic agent is the avian infectious bronchitis coro-
navirus (IBV), which is a Gamma coronavirus of the coro-
navirus genus and replicates primarily in the upper
respiratory tract, kidney, and oviduct of chickens [1-3].
Knowledge of the interactions between virus and host
is critical in order to understand the pathogenesis of
viral infection. On the one hand, the virus usurps the
biological processes of the host to evade the innate
immune response of the host; on the other hand, the
host mounts a variety of defensive responses against the
viral infection. These virus-host interactions can cause
changes in the level of expression of host genes. Altera-
tion of gene expression in the host after infection with
coronavirus (CoV) has been investigated mainly with
regard to infection with mouse hepatitis virus (MHV)
and severe acute respiratory syndrome coronavirus
(SARS-CoV) [4]. Limited studies have been performed
to analyze host gene expression in response to IBV
infection at the transcriptional level using microarray
technology [5,6]. However, the altered levels of tran-
scription do not reflect the proteomic changes that fol-
low viral infection completely. Therefore, information
about proteome changes in the host following IBV
infection may be crucial in order to understand the host
response to the virus and viral pathogenesis.
In the post-genome era, proteomic analysis can provide
insights into the complexity of virus-host interactions.
Proteomic approaches have been utilized to investigate the
proteome changes in cells infected in vitro with classical
swine fever virus [7], infectious bursal disease virus [8],
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proteomic approaches have been used widely to study the
mechanisms of viral infection through the comparative
analysis of proteome changes in host tissue in response to
infection in vivo by Marek’s disease virus [11] and yellow
head virus [12]. More recently, two-dimensional gel elec-
trophoresis (2-DE) was used to compare the potential
effect of several different enveloped RNA virus such as
Influenza virus, respiratory syncytial virus (RSV), parain-
fluenza (PIV) and human metapneumovirus (hMPV) on
the host cell proteome [13-16]. In addition, Edward
Emmott revealed changes in the cytoplasmic, nuclear and
nucleolar proteomes in Vero cells and DF-1 cells infected
with IBV using Stable Isotope Labeling by Amino acids in
Cell culture (SILAC) technique [17,18]. Study on identifi-
cation of the incorporated host proteins in purified IBV
particles has also been reported [19]. Whereas, no studies
have been reported to date of the comparative protein
expression profiles of chicken embryonic tissues in
response to IBV infection either in vitro or in vivo.
In the present study, we made use of two-dimensional
gel electrophoresis (2-DE) coupled with matrix-assisted
laser desorption/ionization time-of-flight tandem mass
spectrometry (MALDI-TOF-TOF MS) analysis to
observe changes of protein expression in the trachea
and kidney tissues of chicken embryos after IBV infec-
tion in ovo. The results may provide the clues that will
increase our understanding of the IBV-host interaction
and the pathogenesis of IBV.
Results
IBV infection in chicken embryos
Seventy-two hours after inoculation with the IBV vaccine
H120 strain, all IBV-infected chicken embryos showed
obvious signs of IBV infection, such as dwarfing, stunt-
ing, curling, and embryonic death. In contrast, the mock-
infected chicken embryos were healthy (Figure 1). Analy-
sis of allantoic fluids from embryos in the IBV-infected
group by EM showed the presence of virus particles with
typical Coronavirus morphology; these were not detected
in the mock-infected group (data not shown). Using RT-
PCR amplification of the majority of the N gene and
parts of the 3’-UTR, the expected 1600bp band was
observed only in samples from the IBV-infected group;
samples from the mock-infected group were negative, as
described previously [20] (data not shown). These results
indicated that chicken embryos in the IBV-infected
group were infected successfully by IBV.
Comparison of differential protein expression in trachea
and kidney tissues between IBV-infected and mock-
infected chicken embryos
In order to investigate the proteomic changes in trachea
and kidney tissues in response to IBV infection, 2-DE
analysis was carried out of the total proteins from tra-
chea and kidney tissues of IBV-infected and mock-
infected chicken embryos. Figure 2 shows representative
gels of tracheal tissue proteins resolved on 13 cm pH 4-
7 IPG strips followed by SDS-PAGE: 1035 ± 47 and
1030 ± 61 protein spots were detected in 2-DE gels
from the IBV-infected group and mock-infected group,
respectively. Figure 3 shows representative gels of tra-
cheal tissue proteins resolved on 13 cm linear pH 3-10
IPG strips followed by SDS-PAGE: 1248 ± 28 and 1060
± 18 protein spots were detected in 2-DE gels from the
IBV-infected group and mock-infected group, respec-
tively. Thirty protein spots showed statistically signifi-
cant changes in expression in chicken embryonic
tracheal tissues from the IBV-infected group compared
with those of the mock-infected group using Image
Master Software analysis. Figure 4 shows representative
gels of kidney tissue proteins resolved on 13 cm linear
pH 3-10 IPG strips followed by SDS-PAGE: 1125 ± 32
and 1074 ± 116 protein spots were detected in 2-DE
gels from the IBV-infectedg r o u pa n dm o c k - i n f e c t e d
group, respectively. Quantitative analysis revealed that
23 protein spots showed statistically significant changes
in expression in chicken embryonic kidney tissues from
the IBV-infected group compared with those from the
mock-infected group.
A magnified comparison of eleven differentially
expressed protein spots, representing ANXA1, HSPB1,
MYLPF, TRIM27.2, EXFABP, ANXA5, PRDX1, TPM1,
ENO1, ANXA2 and CALB, is shown in Figure 5.
Identification of differentially expressed proteins by
MALDI-TOF-TOF MS and MS/MS analysis
All protein spots that showed differential changes in
expression of 1.5 fold or greater (p < 0.05) were analyzed
by MALDI-TOF-TOF MS and MS/MS analysis. The PMF
and MS/MS spectral data were searched against the
NCBInr database using MASCOT. As shown in Table 1,
17 proteins from tracheal tissues were identified success-
fully. Proteins increased in abundance included extracellu-
lar fatty acid-binding protein (EXFABP), a putative
uncharacterized protein (TRIM27.2), ubiquitin carboxyl-
terminal esterase L1 (UCHL1), replication factor C (activa-
tor 1) 2, a cholinergic receptor (nicotinic, gamma polypep-
tide precursor), ARP2 actin-related protein 2 homolog,
ovotransferrin, a second cholinergic receptor (nicotinic,
alpha 7 precursor), chaperonin containing TCP1 subunit
8, and ovoinhibitor precursor. Proteins decreased in abun-
dance included myosin light chain 3 (skeletal muscle iso-
form), myosin light chain 1 (skeletal muscle isoform),
myosin light chain type 2 (MYLPF), heat shock 27 kDa
protein (HSPB1), creatine kinase M chain, annexin A1
(ANXA1) and Rho GDP dissociation inhibitor (GDI)
alpha. Table 2 shows the 19 proteins identified from
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included carbonic anhydrase II, glutathione S-transferase
2, a protein of the sulfotransferase family, L-lactate dehy-
drogenase B, L-3-hydroxyacyl-coenzyme A dehydrogenase,
cystathionase, enolase 1 (ENO1), CNDP dipeptidase 2,
phosphoenolpyruvate carboxykinase, and calbindin-D28 k
(CALB1). Proteins decreased in abundance included tro-
pomyosin beta chain (TPM2), tropomyosin 1 alpha
(TPM1), annexin A5 (ANXA5), peroxiredoxin-1 (PRDX1),
carbonyl reductase 1, NADP-dependent isocitrate dehy-
drogenase, annexin A6 (ANXA6), and MHC class I anti-
gen. Annexin A2 (ANXA2) was identified in two spots
(Figure 4, spots 1 and 12). The abundance of spot 1 was
increased, but spot 12 was decreased. Calbindin-D28 k and
MHC class I antigen were detectable only in the IBV-
infected group because the spots in the mock-infected
group were too weak.
According to the UniProtKB and the Gene Ontology
databases, the identified proteins could be classified into
several functional categories, including cytoskeletal pro-
teins, calcium ion-binding proteins, proteins related to
macromolecule metabolism, anti-oxidative proteins, pro-
tein and nucleotide processing, the ubiquitin-protea-
some pathway, immune response and antigen processing
and presentation, response to stress, signal transduction,
and metal ion binding. Detailed information about the
PMF and MS/MS search results is listed in Additional
file 1, Additional file 2, Additional file 3 and Additional
file 4.
Analysis of identified proteins at the transcriptional level
Alterations in expression of a protein may be due to a
change in its mRNA level. In order to confirm the
results of the proteomics analysis at the mRNA level,
the transcriptional alterations in five selected proteins
from tracheal tissues and six selected proteins from kid-
ney tissues were measured by real-time RT-PCR. Figure
6 shows normalized fold changes of the mRNA of these
AB
Figure 1 Pathological characteristics of IBV-infected chicken embryos compared with mock-infected chicken embryos. (A) The chicken
embryos in the IBV-infected group showed obvious sign of IBV infection, such as dwarfing, stunting, curling and embryo death at 72 h after
inoculated with IBV. (B) The mock-infected chicken embryos were normal.
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in mock-infected chicken embryos. In tracheal tissues,
the mRNA level of ANXA1, HSPB1, and MYLPF was
decreased in IBV-infected chicken embryos by 0.32,
0.39, 0.31 fold, respectively, compared with mock-
infected chicken embryos. The mRNA level of
TRIM27.2 and EXFABP was increased by 1.28 and 1.52
fold, respectively, and the trends of the changes in their
mRNA levels were similar to the patterns of change in
their corresponding proteins on 2-DE gels. For kidney
tissues, the trends of change in the mRNA levels of
ANXA5, PRDX1, TPM1, and ENO1 were consistent
with the 2-DE results. Interestingly, ANXA2 had results
that contrasted with those of the 2-DE methods. CALB1
was found to show no obvious difference between the
IBV-infected group and the mock-infected group.
Protein validation by Western blotting
To further confirm the protein alterations during IBV
infection identified by 2-DE and MALDI-TOF/TOF
mass spectrometry, the protein annexin A5 and HSPB1
were selected for Western blotting analysis and GAPDH
as loading control. As shown in Figure 7, the abundance
of annexin A5 was decreased in kidney tissues of IBV-
infected group compared to mock-infected group, and
the abundance of HSPB1 was decreased in tracheal tis-
sues of IBV-infected group compared to mock-infected
group. The results were consistent with the expression
change shown by the 2-DE analysis.
Discussion
Virus infection and the host response involve a complex
interplay of host and viral networks in which many
viruses attempt to subvert host cell processes to increase
the efficiency of virus infection, and likewise the host
employs a number of responses to generate an anti-viral
state [17]. Coronavirus (CoV) infection can cause altera-
tions in the transcription and translation patterns, cell
cycle, cytoskeleton, and apoptosis pathways of the host
cell [4]. The trachea and kidney are the primary target
organs of IBV, investigation of the proteomic changes in
these tissues after IBV infection in ovo helps to elucidate
the IBV-host interaction and the pathogenic mechan-
isms of IBV. In this study, proteomic methods coupled
with real-time RT-PCR and western blotting were
applied to identify the differentially expressed proteins
in trachea and kidney tissues of IBV-infected and mock-
infected chicken embryos. We now attempt to interpret
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Figure 2 Analysis using 2-DE of chicken embryo tracheal tissues from the IBV-infected group compared with the mock-infected group
using the pH 4-7 range. Protein samples were separated on 13 cm pH 4-7 IPG strips, followed by SDS-PAGE, and stained with Coomassie Blue
R-350. The images were analyzed using Image Master 2D Platinum 6.0 software. The different protein spots identified were marked with a circle
and a number. The numbers assigned to the mapped protein spots correspond to the proteins listed in Table 1.
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during IBV infection in ovo.
In our study, one of the major findings was that the
abundances of some cytoskeletal proteins including
TPM1 and MYLPF were decreased in the IBV-infected
group. Their alterations were also confirmed at the
mRNA level by real-time RT-PCR. Tropomyosin
belongs to the family of actin-binding proteins that
serves important functions in microfilament stabiliza-
tion, regulation of microfilament branching, actin poly-
merization, and intracellular transport [21]. Myosins are
a large superfamily of motor proteins that are involved
in movement along actin filaments, the development of
myriad cells, targeted organelle transport, endocytosis,
chemotaxis, cytokinesis, and signal transduction [22].
Similar result was observed in the IBV-infected cells by
using SILAC technique [17,18]. Changes in cytoskeleton
proteins have been reported in other virus infection in
vitro, including infectious bursal virus [8], H9N2 avian
influenza virus [23], respiratory syncytial virus [16], and
SARS-associated CoV [10]. During the process of virus
infection, particularly in the stages of virus entry and
virus budding, the cytoskeletal network of the host cell
is involved in the transport of viral components within
the cell. Moreover, some viral proteins can interact with
the cytoskeletal transport machinery, such as actin-bind-
ing proteins or actin, and induce rearrangements of
cytoskeletal filaments so that they can utilize them as
tracks or push them aside when they represent barriers
[24]. In the present study, several actin-binding proteins,
including TPM1 and MYLPF, their abundance were
found to be decreased in the IBV-infected group, which
suggests that IBV may also manipulate the host cytoske-
letal network for its own infectious processes and
replication.
It is well known that Ca
2+ is one of the most universal
and versatile signaling molecule, and involved in almost
every aspect of cellular processes. The Ca
2+ plays impor-
tant roles in virus entry, viral gene expression, posttran-
slational processing of viral proteins, and the maturation
and release of virions. Viruses can utilize host cellular
Ca
2+ and Ca
2+-binding proteins to create a tailored cel-
lular environment that meets their own demands for the
replication cycle [25]. In this study, the level of expres-
sion of some calcium ion-binding proteins, including
Calbindin-D28 k, annexin A1, annexin A2, annexin A5,
and annexin A6 were altered after IBV infection in ovo.
Calbindin-D28 k is a cytosolic calcium-binding protein
that facilitates 1, 25 (OH)2D3 dependent transcellular
calcium transport. It was also observed to protect
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Figure 3 Analysis using 2-DE of chicken embryo tracheal tissues from the IBV-infected group compared with the mock-infected group
using the pH 3-10 range. Protein samples were separated on 13 cm linear pH 3-10 IPG strips, followed by SDS-PAGE, and stained with
Coomassie Blue R-350. The images were analyzed using Image Master 2D Platinum 6.0 software. The different identified protein spots were
marked with a circle and a number. The numbers assigned to the mapped protein spots correspond to the proteins listed in Table 1.
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study, its abundance was remarkably increased in the
IBV-infected group, which suggests that IBV might spe-
cially utilize calbindin-D28 k to perturb the cellular Ca
2+
homeostasis and Ca
2+-signaling network for its own
benefit. Annexins are a family of structurally related
proteins that bind phospholipids and cellular mem-
branes in a calcium-dependent manner [28]. Annexin
A2 has been shown to take part in the initiation of
membrane fusion in exocytosis, membrane trafficking,
regulation of cell proliferation and apoptosis, and stabili-
zation of membrane-associated protein complexes with
the actin cytoskeleton [29,30]. In addition, Annexin A2
can promote the entry of human immunodeficiency
virus (HIV) into monocyte-derived macrophages [29],
and it was also identified to be a potential receptor for
respiratory syncytial virus on human epithelial cells [31].
Annexin A2 on the lung epithelial cell surface was
recognized by SARS-associated CoV spike domain 2
antibodies and identified as an autoantigen [32].
Annexin A5 was found to be involved in cytomegalo-
virus infection [33] and influenza virus infection [34].
Annexin A1 plays a critical role in a variety of cellular
processes such as proliferation, differentiation, and
apoptosis [35]. Its abundance was shown to be increased
in HepaRG cells infected with hepatitis B virus (HBV) in
vitro [36], and fish cells infected in vitro with infectious
pancreatic necrosis virus [37]. Changes in the abundance
of some annexins family proteins also were identified in
IBV-infected DF-1 cells by Edward Emmott and co-
workers [18]. In current study, the abundance of
annexin A1, annexin A5, and annexin A6 were all
decreased in the IBV-infected group. For annexin A2,
two spots were identified in kidney tissue, the abun-
dance of one spot was increased, and another spot was
decreased. Of these, the decrease of annexin A5 was
confirmed by real-time RT-PCR and western blotting
analysis. These data suggested that they may play special
roles during IBV infection or replication.
Remarkably, several stress response and anti-oxidative
proteins were found to be changed significantly in the
present study. HSPB1 is an important small heat shock
protein (HSP) that is synthesized in response to a wide
variety of stressful stimuli, including viral infection. It
has diverse functions including chaperone activity, F-
actin modulation, signal transduction, resistance to
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Figure 4 Analysis using 2-DE of chicken embryo kidney tissues from the IBV-infected group compared with the mock-infected group
using the pH 3-10 range. Protein samples were separated on 13 cm linear pH 3-10 IPG strips, followed by SDS-PAGE, and stained with
Coomassie Blue R-350. The images were analyzed using Image Master 2D Platinum 6.0 software. The different identified protein spots were
marked with a circle and a number. The numbers assigned to the mapped protein spots correspond to the proteins listed in Table 2.
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Page 6 of 17oxidant stress, regulation of translational initiation, and
modulation of inflammation, inhibition of apoptosis, and
cell differentiation and proliferation [38,39]. Enhanced
levels of HSPB1 and/or phosphoHSPB1 can promote
nuclear transport of adenovirus in MK2-deficient cells
[40]. The abundance of HSPB1 has found to be
increased in cells infected in vitro with H9N2 avian
influenza virus [23], African swine fever virus [41], and
infectious bursal disease virus [8]. In contrast, its abun-
dance was found to be decreased in cells infected in
vitro with mumps virus [42] and porcine circovirus type
2 [9], which suggests that HSPB1 may play different
roles in different virus infections or different stages of
infection. PRDX1 is the most ubiquitously expressed
member of the peroxiredoxin family, which is involved
in anti-oxidative processes, cell differentiation and pro-
liferation, immune responses, regulation of apoptosis,
and as a molecular chaperone [43]. PRDX1 participates
in the apoptosis signal-regulating kinase 1 (ASK1)-
mediated signaling pathway, and plays an inhibitory role
in ASK1-induced apoptosis [44]. Its abundance was
shown to be decreased in peripheral blood mononuclear
cell (PBMC) following CSFV infection in vivo [45]. In
our study, the abundance of HSPB1 and PRDX1 were
shown to be decreased after IBV infection in ovo by 2-
DE and real-time RT-PCR methods. Furthermore, the
change of HSPB1 expression was confirmed by western
blotting. This alteration may allow the infected cells to
be eliminated by apoptosis, or serve as a form of host
defense against IBV infection.
Viral replication requires energy and macromolecular
precursors derived from the metabolic network of the
host. In the present results obtained using 2-DE, the
abundance of some proteins which are associated with
carbohydrate, amino acid, and lipid metabolic processes
were found to be differentially changed. Enolase-1 is a
key enzyme of glycolysis and gluconeogenesis that cata-
lyzes the dehydration of 2-phosphoglycerate to phos-
phoenolpyruvate [46]. Its abundance was found to be
changed in many virus infections, such as white spot
syndrome virus [47], and porcine reproductive and
respiratory syndrome virus [48]. Phosphoenolpyruvate
carboxykinase is another gluconeogenic enzyme; it cata-
lyzes the GTP-driven conversion of oxaloacetate to
phosphoenolpyruvate [49]. Increased expression of pro-
teins related to energy metabolism was also found in
HIV-infected peripheral blood mononuclear cells [50],
chicken spleen tissue infected with Marek’s disease virus
Mock-infected IBV-infected Mock-infected IBV-infected
TPM1
ANXA5
EXFABP
PRDX1
TRIM27.2
ANXA2
HSPB1
ENO1
MYLPF
CALB1
ANXA1
Figure 5 Comparison of enlarged images of representative differentially expressed protein spots. The enlarged images of ANXA1, HSPB1,
MYLPF, TRIM27.2, EXFABP, ANXA5, PRDX1, TPM1, ENO1, ANXA2 and CALB protein spots are shown. The numbers assigned to the mapped
protein spots correspond to the proteins listed in Table 1 or Table 2.
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Page 7 of 17Table 1 List of differentially expressed protein spots in tracheal tissues identified by MALDI-TOF-TOF MS and MS/MS analysis
Spot
a Accession
Number
b
Protein Description Mr
(KDa)/
pI
Score Coverage
(%)
d
Normalized spot
volume (vol%)
e
p Ratio
(infected/
mock-
infected)
Protein functions Other viruses
found in
f
Mock-
infected
IBV-
infected
Cytoskeletal and calcium ion-binding proteins
1 gi|
55584150
Myosin light chain 3, skeletal
muscle isoform [Gallus gallus]
16.7/
4.52
81
c 38 0.1007 ±
0.0245
0.0452 ±
0.0118
0.024 0.45 Motor activity. Calcium ion binding. IAV, RSV, CVB3
2 gi|212347 Myosin light chain 1, skeletal
muscle isoform [Gallus gallus]
19.5/
4.96
192 53 0.6040 ±
0.0519
0.3576 ±
0.0656
0.007 0.59 Motor activity. Calcium ion binding.
16 gi|
50403707
myosin light chain type 2
(LC2f) [Gallus gallus]
18.9/
4.77
220 33 0.4716 ±
0.0545
0.2784 ±
0.0257
0.005 0.59 Motor activity. Calcium ion binding. VHSV
18 gi|
46195459
annexin A1 [Gallus gallus] 38.5/
7.05
142
c 39 0.1277 ±
0.0106
0.0596 ±
0.0118
0.002 0.47 Calcium/phospholipid-binding protein. Promotes
membrane fusion. Involved in exocytosis. Regulates
phospholipase A2 activity. Inflammation response
CSFV, PRRSV, HBV,
RSV, VHSV, WNV
Carbohydrate and lipid metabolic proteins
3 gi|
20178282
Extracellular fatty acid-binding
protein [Gallus gallus]
20.1/
5.56
361 46 0.0495 ±
0.0094
0.1058 ±
0.0221
0.015 2.14 Fatty acid binding and transporting. Inflammatory
response.
17 gi|
45382875
Creatine kinase M chain
[Gallus gallus]
43.3/
6.5
287 50 0.5632 ±
0.0122
0.2546 ±
0.0488
<
0.001
0.45 Nucleotide binding. Catalytic activity. Creatine kinase
activity
HBV, VHSV
Stress response protein
15 gi|
45384222
Heat shock 27 kDa protein
[Gallus gallus]
21.7/
5.77
166 61 0.2906 ±
0.0637
0.1531 ±
0.0432
0.036 0.53 Response to stress. Anti-apoptosis CSFV, PRRSV,
PCV2, ASFV, AIV,
MDV, IBDV, REOV,
1AV, CVB3
Protein and nucleotide processing
5 gi|
122692295
ubiquitin carboxyl-terminal
esterase L1 [Gallus gallus]
25.1/
5.74
142 31 0.0563 ±
0.0019
0.0980 ±
0.0071
0.001 1.74 Ubiquitin binding, Protein deubiquitination DHBV, IBDV
6 gi|
45382983
replication factor C (activator
1) 2, 40 kDa [Gallus gallus]
40.1/
5.68
87
c 45 0.0542 ±
0.0128
0.1931 ±
0.0297
0.002 3.56 Nucleotide binding. ATP binding
10 gi|
52138673
chaperonin containing TCP1,
subunit 8 (theta) [Gallus
gallus]
59.5/
5.35
300 37 0.0403 ±
0.0031
0.0760 ±
0.0047
0.001 1.89 Protein binding. Nucleotide binding PRRSV, EV71,
HPV8, IAV
11 gi|
52138673
chaperonin containing TCP1,
subunit 8 (theta) [Gallus
gallus]
59.5/
5.35
356 47 0.0559 ±
0.0021
0.1228 ±
0.0375
0.037 2.20 Protein binding. Nucleotide binding PRRSV, EV71,
HPV8, IAV
4 gi|
150247116
Putative uncharacterized
protein TRIM27.2 (Tripartite
motif-containing) [Gallus
gallus]
27.2/
5.25
289
c 46 0.0792 ±
0.0116
0.2098 ±
0.0196
0.001 2.65 Protein binding. Metal ion binding
9 gi|
45383758
cholinergic receptor, nicotinic,
alpha 7 precursor [Gallus
gallus]
56.9/
5.47
159
c 29 0.0323 ±
0.0055
0.0723 ±
0.0182
0.022 2.24 Acetylcholine receptor activity. Activation of MAPK
activity. Cellular calcium ion homeostasis
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7Table 1 List of differentially expressed protein spots in tracheal tissues identified by MALDI-TOF-TOF MS and MS/MS analysis (Continued)
7 gi|
71896049
cholinergic receptor, nicotinic,
gamma polypeptide
precursor [Gallus gallus]
59.6/
5.53
142
c 26 0.0701 ±
0.0132
0.1207 ±
0.0039
0.003 1.72 Nicotinic acetylcholine-activated cation-selective
channel activity. Ion channel activity
8-1 gi|
45382569
ARP2 actin-related protein 2
homolog [Gallus gallus]
45.0/
6.3
157
c 51 0.0747 ±
0.0027
0.1336 ±
0.0187
0.006 1.79 ATP binding. Actin binding. Protein binding
13 gi|
71895337
ovoinhibitor precursor [Gallus
gallus]
54.4/
6.16
128
c 39 0.0334 ±
0.0139
0.1046 ±
0.0364
0.034 3.13 Serine-type endopeptidase inhibitor activity.
Peptidase inhibitor activity.
14 gi|
71895337
ovoinhibitor precursor [Gallus
gallus]
54.4/
6.16
291 40 0.0545 ±
0.0228
0.1074 ±
0.0119
0.029 1.97 Serine-type endopeptidase inhibitor activity.
Peptidase inhibitor activity.
Signal transduction
12 gi|
124249432
Rho GDP dissociation
inhibitor (GDI) alpha [Gallus
gallus]
23.3/
5.22
264 60 0.1091 ±
0.0127
0.0619 ±
0.0131
0.011 0.57 Rho GDP-dissociation inhibitor activity. Signal
transduction
CSFV, RSV, WSSV,
YHV, IBDV
Metal ion binding
8-2 gi|
17942831
Chain A, Ovotransferrin, C-
Terminal Lobe, Apo Form
39.4/
6.31
93
c 49 0.0747 ±
0.0027
0.1336 ±
0.0187
0.006 1.79 Metal ion binding. Iron ion transport
a) Spot ID: is the unique number which refers to the labels in Figure 2 and Figure 3.
b) Accession Number: gi number in NCBI.
c) Score: Protein score based only on MS spectra by MALDI-TOF, other spots based on combined MS and MS/MS spectra from MALDI-TOF-TOF identification, a protein score greater than 83 is significant in this study
(p < 0.05).
d) Coverage (%): Percentage of identified protein sequences covered by matched peptides.
e) Values are presented as mean ± SD. n = 3; vol % was defined as the ratio of the intensity volume of each spot to that of all spots calculated by the software. The SD represents standard deviation of the vol % in
three biological replicates.
f) IAV, Influenza A virus; RSV, Human respiratory syncytial virus; CVB3, coxsackievirus B3; VHSV, Viral haemorrhagic septicemia virus; CSFV, classical swine fever virus; PRRSV, Porcine reproductive and respiratory
syndrome virus; PCV2, Porcine circovirus type 2; ASFV, African swine fever virus; HBV, Hepatitis B virus; AIV, Avian influenza virus; EV71, Enterovirus 71; MDV, Marek’s disease virus; WSSV, White spot syndrome virus;
DHBV, Duck heptatitis B virus; YHV, yellow head virus; HPV8, Human papillomavirus type 8; REOV, Reovirus; IBDV, Infectious bursal disease virus.
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7Table 2 List of differentially expressed protein spots in kidney tissues identified by MALDI-TOF-TOF MS and MS/MS analysis
Spot
a Accession
Number
b
Protein Description Mr
(KDa)/
pI
Score Coverage
(%)
d
Normalized spot
volume (vol%)
e
p Ratio
(infected/
mock-
infected)
Protein function Other viruses found in
f
Mock-
infected
IBV-
infected
Cytoskeletal proteins
2 gi|515694 Tropomyosin beta chain [Gallus
gallus]
28.5/
4.65
123 31 0.2134 ±
0.0092
0.0524 ±
0.0162
<
0.001
0.25 Actin binding HBV, HCV, WSSV
3 gi|
45382323
Tropomyosin 1 alpha [Gallus
gallus]
32.9/
4.73
307 57 0.1907 ±
0.0219
0.0474 ±
0.0188
0.001 0.25 Actin binding PRRSV, RSV, HPV8, VHSV,
CVB3
Calcium ion-binding proteins
1 gi|
45382533
annexin A2 [Gallus gallus] 38.7/
6.92
389 67 0.0388 ±
0.0177
0.2153 ±
0.0838
0.023 5.55 Phospholipase inhibitor activity. Calcium
ion binding
CSFV, PRRSV, HBV, HIV,
DHBV, WNV
12 gi|
45382533
annexin A2 [Gallus gallus] 38.6/
6.92
505 69 0.5186 ±
0.1260
0.1549 ±
0.0474
0.009 0.3 Phospholipase inhibitor activity. Calcium
ion binding
4 gi|
71895873
annexin 5 [Gallus gallus] 36.2/
5.6
402 71 0.4276 ±
0.0516
0.1898 ±
0.0334
0.003 0.44 Calcium ion binding. Calcium-
dependent phospholipid binding
PRRSV, DV, DHBV, HBV,
VHSV
17 gi|
50982399
annexin A6 [Gallus gallus] 75.2/
5.57
441 49 0.4317 ±
0.0389
0.1653 ±
0.0107
<
0.001
0.38 Calcium ion binding. Calcium-
dependent phospholipid binding
19 gi|
45382893
calbindin 1, 28 kDa [Gallus gallus] 30.4/
4.72
212 60 N/A 0.1485 ±
0.0614
0.014 N/A Calcium ion binding. Vitamin D binding
20-1 gi|
45382893
calbindin 1, 28 kDa [Gallus gallus] 30.2/
4.72
285 50 N/A 0.1527 ±
0.0545
0.008 N/A Calcium ion binding. Vitamin D binding
Carbohydrate and lipid metabolic proteins
5 gi|
46048696
carbonic anhydrase II [Gallus
gallus]
29.4/
6.56
354 75 0.2622 ±
0.0554
0.4806 ±
0.0850
0.020 1.83 Morphogenesis of an epithelium. One-
carbon metabolic process
8 gi|
71895267
carbonyl reductase 1 [Gallus
gallus]
30.5/
8.5
357 82 0.1847 ±
0.0160
0.0909 ±
0.0220
0.004 0.49 Catalytic activity. Oxidoreductase activity VHSV
10 gi|
45383766
L-lactate dehydrogenase B [Gallus
gallus]
36.3/
7.07
306 40 0.3102 ±
0.0260
0.6368 ±
0.1152
0.009 2.05 Glycolysis. Oxidoreductase activity,
acting on the CH-OH group of donors,
NAD or NADP as acceptor
PRRSV, HBV, HIV, IBDV,
REOV
11 gi|
118090053
similar to L-3-hydroxyacyl-
Coenzyme A dehydrogenase,
short chain [Gallus gallus]
34.4/
8.68
135 39 0.0814 ±
0.0048
0.2186 ±
0.0820
0.044 2.69 Catalytic activity. Oxidoreductase
activity. Fatty acid metabolic process
14 gi|
118093509
PREDICTED: similar to cytosolic
NADP-dependent isocitrate
dehydrogenase [Gallus gallus]
46.6/
8.02
412 47 0.2077 ±
0.0198
0.0942 ±
0.0092
0.001 0.45 Oxidoreductase activity PRRSV, PCV2, HBV, RSV
15 gi|
46048768
enolase 1 [Gallus gallus] 47.3/
6.17
387 57 0.5718 ±
0.1537
1.2489 ±
0.0439
0.002 2.18 Glycolysis PRRSV, PCV2, WSSV, HSV-1,
RSV, DHBV, HIV, IBDV, HBV,
VHSV, WNV, SARS-CoV
18 gi|
110591367
Chain A, The Structure Of
Chicken Mitochondrial Pepck
67.3/
6.55
441 49 0.0866 ±
0.0138
0.1704 ±
0.0253
0.007 1.97 Gluconeogenesis HBV, SARS-CoV
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7Table 2 List of differentially expressed protein spots in kidney tissues identified by MALDI-TOF-TOF MS and MS/MS analysis (Continued)
Amino acid metabolic proteins
6 gi|2981970 glutathione S-transferases 2
[Gallus gallus]
25.8/
7.0
437 68 0.1877 ±
0.0201
0.4192 ±
0.0767
0.007 2.23 Amino acid metabolic process HBV
13 gi|
118094764
PREDICTED: similar to
cystathionase [Gallus gallus]
43.9/
6.86
399 35 0.1704 ±
0.0390
0.3164 ±
0.0547
0.02 1.86 Cysteine biosynthetic process
Antioxidative stress proteins
7 gi|
50751518
PREDICTED: similar to
peroxiredoxin-1 [Gallus gallus]
22.3/
8.24
252 42 0.5474 ±
0.0371
0.1253 ±
0.0600
<
0.001
0.23 Response to oxidative stress. Removal
of superoxide radicals. Regulation of
stress-activated MAPK cascade
CSFV, PRRSV, RSV, SARS-
CoV, HBV, IAV
Protein processing
16 gi|
57530409
CNDP dipeptidase 2 [Gallus
gallus]
53.1/
5.71
403 52 0.1743 ±
0.0319
0.3196 ±
0.0759
0.038 1.83 Proteolysis
9 gi|
45382969
sulfotransferase family, cytosolic,
1C, member 3 [Gallus gallus]
36.2/
6.68
245 47 0.1481 ±
0.0412
0.2923 ±
0.0578
0.024 1.97 Sulfotransferase activity. Detoxicating
Immune response proteins
20-2 gi|
54606655
MHC class I antigen [Gallus
gallus]
37.6/
6.09
385
c 71 N/A 0.1527 ±
0.0545
0.008 N/A Immune response. Antigen processing
and presentation
BVDV
a) Spot ID: is the unique number which refers to the labels in Figure 4.
b) Accession Number: gi number in NCBI.
c) Score: Protein score based only on MS spectra by MALDI-TOF, other spots based on combined MS and MS/MS spectra from MALDI-TOF-TOF identification, a protein score greater than 83 is significant in this study
(P < 0.05).
d) Sequence coverage (%): Percentage of identified protein sequences covered by matched peptides.
e) Values are presented as mean ± SD. n = 3; vol % was defined as the ratio of the intensity volume of each spot to that of all spots calculated by the software. The SD represents standard deviation of the vol % in
three biological replicates.
N/A: A indicates the spot was detectable on one of the gels, N indicates the spot was too weak to detect on one of the gels.
f) HCV, Hepatitis C virus; VSV, Vesicular stomatitis virus; HSV-1, Herpes simplex virus type-1; DV, Dengue virus; HIV, Human immunodeficiency virus; SARS-CoV, Severe acute respiratory syndrome -associated
coronavirus; VHSV, Viral haemorrhagic septicemia virus; WNV, West Nile virus; BVDV, Bovine viral diarrhea virus.
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7[11], and human cytomegalovirus-infected human fibro-
blasts [51]. The abundance of L-lactate dehydrogenase B
also found to be increased in IBV-infected cells by
SILAC technique [17,18]. Up-regulation of proteins
related to energy metabolism may meet the requirement
for a large burst of oxygen and energy during rapid
virus replication, and also may result from an attempt
by the host to keep up with the energy demand during
viral infection. Ex-FABP is 21 kDa lipocalin that is
involved in fatty acid transport and lipid metabolism. It
may play an important role in the protection of cells
against the toxic effects of the accumulation of fatty
acids. The expression of Ex-FABP is enhanced greatly in
response to inflammatory stimuli and other stress condi-
tions [52,53]. In this study, its abundance was signifi-
cantly increased in tracheal tissue of IBV-infected
chicken embryos, suggesting may serve as a response to
the inflammation induced by IBV infection in ovo.
The abundance of several proteins which involved in
the immune response and antigen processing and presen-
tation were also observed to be changed in this study.
TRIM protein is a member of a protein family that is
based on a conserved domain architecture characterized
by a RING finger domain, one or two B-box domains, a
coiled-coil domain and a variable C-terminus. TRIM pro-
teins are involved in a variety of cellular processes that
include signal transduction, transcriptional regulation,
cell proliferation, apoptosis, and immunity [54]. Many
TRIM proteins, such as TRIM5a,T R I M 1 1 ,T R I M 2 2 ,
TRIM28, TRIM31, and TRIM62, have been found to dis-
play antiviral activity or to be involved in processes asso-
ciated with innate immunity [55-57]. An extended gene
map revealed that TRIM27.2 lies within a sub-region of
the chicken MHC-B that affects infectious disease [58].
The major histocompatibility complex (MHC) plays an
important role in regulation of the immune response and
antigen presentation. The transcription levels of the
MHC class II-associated invariant chain and MHC class
II b chain were observed to be increased in tracheal
epithelial layers of chickens three days after infection
with an attenuated IBV-Massachusetts strain [6]. In cur-
rent study, the abundance of TRIM27.2 and MHC class I
antigen were increased remarkably following IBV infec-
tion in ovo. According to our knowledge, TRIM27.2 has
never been found in other virus analysis so far. This
change might be induced specially by IBV infection.
Conclusions
In summary, we have performed the first analysis of the
proteomic changes in chicken embryonic trachea and
kidney tissues during IBV infection in ovo. We identified
a series of proteins that are related mainly to the
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Figure 6 Transcript alteration of eleven selected genes in chicken embryo tissues from the IBV-infected group compared with the
mock-infected group. Total RNA extracted from tracheal or kidney tissues was measured by real-time RT-PCR analysis; relative expression levels
were calculated according to the 2
-ΔΔCT method, using GAPDH as an internal reference gene and the mock-infected group as calibrator (relative
expression = 1). Error bar shows the standard deviation. Gene symbols indicating different genes refer to Table 1 or Table 2.
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Page 12 of 17cytoskeleton, calcium ion binding, the stress response,
anti-oxidative stress, and macromolecular metabolism.
Notably, some of the identified proteins have the ability
to regulate apoptosis. Our study should facilitate a bet-
ter understanding of the pathogenic mechanisms of IBV
infection. Future work will focus on the analysis of the
specific roles of some interesting proteins during IBV
infection.
Materials and methods
Experimental animals and virus infection
Eighteen 13-day-old SPF chicken embryos (Harbin
Veterinary Research Institute, China) were divided ran-
domly into two groups, the IBV-infected group and
the mock-infected group (nine chicken embryos in
each group). Each chicken embryo in the IBV-infected
group was inoculated with 100 μl chorioallantoic fluid
containing IBV H120 strain (10
5-10
6EID50). As a
control, each chicken embryo in the mock-infected
group was inoculated in parallel with 100 μls t e r i l e
chorioallantoic fluid. The inoculated chicken embryos
were incubated at 37°C and candled daily to check for
embryonic viability.
Seventy-two hours after inoculation, the inoculated
embryos were examined for characteristics of IBV infec-
tion. All the allantoic fluid was harvested from the IBV-
infected and mock-infected chicken embryos to test for
the presence of IBV using electron microscopy (EM),
and for reverse transcriptase-polymerase chain reaction
(RT-PCR) amplification of the majority of the N gene
and parts of the 3’-UTR, as described previously [3,59].
Trachea and kidney tissues were removed quickly from
the chicken embryos. Tissue samples from three ran-
domly selected chicken embryos per group were pooled,
and the pooled tissue samples were stored immediately
at -80°C for 2-DE and real-time RT-PCR analysis.
Mock-infected group IBV-infected group
ANXA5
GAPDH
HSPB1
GAPDH GAPDH
Figure 7 Western blotting analysis confirmation of representative protein in IBV-infected and mock-infected chicken embryo tissues.
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Page 13 of 17Protein sample preparation
The frozen tissues were rinsed in ice-cold PBS buffer,
then placed in liquid nitrogen and ground thoroughly to
av e r yf i n ep o w d e r .T i s s u ep o w d e r( 1 0 0m g )w a sd i s -
solved in 500 μl lysing solution containing 7 M urea, 2
M thiourea, 4% CHAPS, 40 mM DTT, 2% IPG buffer
pH 3-10 or pH 4-7, 1% Nuclease Mix and 1% Protease
Inhibitor Mix (GE Healthcare), then incubated for 2 h
at room temperature with vortexing once every 15 min,
and centrifuged at 15 000 ×g for 1 h at 4°C. The super-
natant was collected and purified with the PlusOne 2D
Clean-up kit (GE Healthcare). The concentration of
each protein sample was determined with the PlusOne
2D Quant Kit (GE Healthcare). Protein samples were
aliquoted and stored at -80°C for 2-DE analysis.
Two-dimensional electrophoresis
Three independent sample pools of each kind of tissue
per group were used for 2-DE analysis respectively. For
tracheal tissue samples, pH 4-7 and linear pH 3-10 IPG
strips were used. For kidney t i s s u es a m p l e s ,o n l yl i n e a r
pH 3-10 IPG strips were used. Briefly, 400 μgp r o t e i n
(for pH 3-10 strips) or 550 μg( f o rp H4 - 7s t r i p s )w e r e
added to the rehydration solution (7 M urea, 2 M
thiourea, 40 mM DTT, 2% CHAPS, 0.5% pH 3-10 or
pH 4-7 IPG buffer, and 0.002% bromophenol blue) to
make the final volume up to 250 μl, then loaded onto
13 cm, pH 4-7 or linear pH 3-10 IPG strips (GE Health-
care). Isoelectric focusing (IEF) was performed on an
Ettan IPGphor 3 (GE Healthcare) using the following
procedure: 12 h at 30 V, 30 min at 200 V, 2 h at 500 V,
1 h at 1000 V, 2 h of a linear gradient from 1000 V to
7000 V, and 7000 V to 55000 Vh. After IEF, the IPG
strips were first equilibrated with gentle shaking for 15
min in an equilibration buffer containing 6 M urea, 50
mM Tris-HCl, pH 8.8, 30% glycerol, 2% SDS, 0.002%
bromophenol blue, and 1% DTT, then for an additional
15 min in the same buffer except that the DTT was
replaced by 2.5% iodoacetamide. For SDS-PAGE, the
IPG strips were placed on 12.5% SDS-polyacrylamide
gels, and electrophoresis was carried out using an SE600
Ruby system (GE Healthcare). The gels were stained
w i t hP l u s O n eC o o m a s s i eB l u eR - 3 5 0( G EH e a l t h c a r e )
according to the manufacturer’s protocol, and destained
with 10% acetic acid solution.
Image acquisition and analysis
The stained 2-DE gels were scanned with an ImageScan-
ner III (GE Healthcare). Spot detection, matching and
quantification analyses were performed with Image Mas-
ter 2D Platinum software v6.0 (GE Healthcare). For
image analysis, three independent gels from the different
sample pools for each group were compared. Protein
spot intensity was defined as the normalized spot
volume (vol %), then the normalized volume values (vol
%) of individual protein spots were subjected to Stu-
dent’s t test using SPSS statistical software package ver-
sion 16.0. The criterion used to define differential
expression of spots was that the ratio of the vol % in the
IBV-infected group vs. the mock-infected group was
more than 1.5 (p < 0.05) or less than 0.67 (p < 0.05).
Differentially expressed protein spots were subjected to
MS analysis.
Protein identification by MALDI-TOF-TOF MS and MS/MS
analysis
The differentially expressed protein spots were excised
manually from the gels, dehydrated in acetonitrile
(ACN), and dried at room temperature. Proteins were
reduced with 10 mM dithiothreitol (DTT) /25 mM
NH4HCO3 at 56°C for 1 h and alkylated with 55 mM
iodoacetamide/25 mM NH4HCO3 in the dark at room
temperature for 45 min in situ. Gel pieces were washed
thoroughly with 25 mM NH4HCO3, 50% and 100%
ACN, and dried in a Speedvac. Dried gel pieces were
rehydrated with 2-3 μl of trypsin (Promega) solution (10
ng/μl in 25 mM ammonium bicarbonate) at 4°C for 30
min. Excess liquid was discarded and the gel plugs were
incubated at 37°C for 12 h. Trifluoroacetic acid (TFA)
was added to a final concentration of 0.1% to stop the
digestive reaction.
The digests were spotted immediately onto 600 μm
Anchorchips (Bruker Daltonics). Spotting was achieved
by pipetting 1 μl of analyte onto the MALDI target plate
in duplicate, then adding 0.05 μl of 2 mg/ml a-cyano-4-
hydroxycinnamic acid in 0.1% TFA/33% ACN, which
contained 2 mM ammonium phosphate. Bruker peptide
calibration mixture was spotted down for external cali-
bration. All samples were allowed to air dry at room
temperature, and 0.1% TFA was used for on-target
washing. All samples were analyzed in the positive-ion,
reflectron mode, on a TOF Ultraflex II mass spectro-
meter (Bruker Daltonics).
Each acquired mass spectrum (m/z range 700-4000,
resolution 15 000-20 000) was processed using the Flex
Analysis software version 2.4 (Bruker Daltonics) with
the following settings: peak detection algorithm set at
SNAP (Sort Neaten Assign and Place), S/N threshold at
3, and Quality Factor Threshold at 50. The trypsin auto-
digestion ion picks (842.51, 1045.56, 2211.10, and
2225.12 Da) were used as internal standards to validate
the external calibration procedure. Matrix and/or auto-
proteolytic trypsin fragments, and known contaminants
(e.g., keratins) were removed. The resulting peptide
mass lists were used first to search the NCBInr database
(release 16/01/2010, 10343571 sequences, 3528215794
residues) for Gallus sequences with MASCOT (v2.3) in
the automated mode; the following parameters were
Cao et al. Proteome Science 2011, 9:11
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Page 14 of 17used as criteria in the search: significant protein
MOWSE score at 83 (p < 0.05), minimum mass accu-
racy at 100 ppm, trypsin as enzyme, one missed cleavage
site allowed, cysteine carbamidomethylation, acrylamide
modified cysteine, methionine oxidation, and the mini-
mum sequence coverage at 15%. The samples identified
by PMF were automatically submitted to MS/MS analy-
sis. Three of the strongest peaks of the TOF spectra per
sample were chosen for MS/MS analysis. For MS/MS
spectra searching, the spectra were used to search the
NCBInr database (release 16/01/2010, 10343571
sequences, 3528215794 residues) for Gallus sequences
using MASCOT (v2.3). The search parameters for MS/
MS data included 100 ppm for the precursor ion and
0.4 Da for the fragment ions. Cleavage specificity and
covalent modifications were considered as described
above, and the score was higher than the minimal signif-
icant (p < 0.05) individual ion score. All significant MS/
MS identifications by MASCOT were verified manually
for spectral quality and matching of the y and b ion
series.
Real-time RT-PCR
Specific primers were designed according to the corre-
sponding gene sequences of MS-identified proteins
using Beacon Designer software 7.5 (Primer Biosoft
International). All the information on the primers is
listed in Table 3. Total RNA was extracted using TRIzol
Reagent (Invitrogen) according to the manufacturer’s
instructions. The concentration and purity of the RNA
were measured using a spectrophotometer (GE Health-
care). Two micrograms of total RNA was reverse tran-
scribed with 200 U M-MLV Reverse Transcriptase
(Invitrogen) and 500 ng Oligo(dT)18 as the first strand
primer in 20 μl reaction solution. Real-time PCR was
carried out on the iCycler
® real-time PCR detection sys-
tem (Bio-Rad Laboratory). Each 25 μl reaction volume
contained 1 μl1 0μM (each) forward and reverse pri-
mers, 12.5 μl2×S Y B R
® Premix Ex Taq™ II (Takara),
and 2 μl 1:10 diluted cDNA products, and the final
volume was adjusted using PCR-water. The following
PCR program was used for amplification: 30 s at 95°C,
40 cycles of denaturation at 95°C for 10s, and annealing
and extension at 55°C for 30 s. Three independent sam-
ple pools per group were analyzed. Quantitative analysis
of the data was performed using the iCycler IQ
5 optical
system software version 2.0 (Bio-Rad Laboratory) in a
Normalized Expression (ΔΔCt) model, using the mock-
infected group as calibrator (relative expression = 1) and
GAPDH as an internal reference gene.
Western blotting analysis
Samples from IBV-infected and mock-infected chicken
embryo kidney tissues and tracheal tissues were lysed
and protein concentrations were determined as
described above. Equivalent amounts of total protein
were subjected to 12% SDS-PAGE and then transferred
to nitrocellulose membrane. After blocking for one hour
at 37°C, the membranes were incubated with mouse
monoclonal antibody to annexin A5 (sc-32321, Santa
Cruz Biotechnology, USA) and mouse monoclonal anti-
body to HSP27 (sc-51956, Santa Cruz Biotechnology,
USA) for overnight at 4°C. The membranes were then
separately incubated with horseradish peroxidase (HRP)-
conjugated anti-mouse IgG (A2554, Sigma, USA) or
IRDye700DX conjugated anti-mouse secondary antibody
(610-130-121, Rockland, Gilbertsville, PA) for one hour
at room temperature, finally visualized using 3,3-diami-
nobenzidine tetrahydrochlo r i d e( D A B )a st h es u b s t r a t e
or scanned on a LI-COR infrared imaging system using
their Odyssey software (Li-Cor Bioscience, Lincoln, NE).
HRP-conjugated monoclonal mouse anti-GAPDH
(ab9482, Abcam, USA) was used as reference protein to
check equal loading. Triplicates were performed.
Table 3 The primers used for real-time RT-PCR
Gene symbol Gene accession No. Forward primer sequence (5’-3’) Reverse primer sequence (5’-3’) Amplicon size (bp)
ANXA2 NM_205351 CTGTGATTGACTATGAACTGATTG TTAACTTCCTTCTTGATGCTCTC 196
ANXA5 NM_001031538 GGCTGGCACTGATGATGATACC CCACCACAGAGGAGCAGGAG 171
PRDX1 XM_001233859 CTGCTGGAGTGCGGATTG AGAGGGTAGAAGAAGAACACAAC 186
TPM1 NM_205401 CATTGCTGAAGAGGCTGAC CGGACTTGGCTTTCTGATAG 114
CALB1 NM_205513 AGGCAGGCTTGGACTTAAC GCTGGCACCTAAAGAACAAC 141
ENO1 NM_205120 AATGGATGGAACGGAGAAC AGCAAGGTCAGCAATGTG 127
ANXA1 NM_206906 GGACAACCAGGAGCAGGAATG TGGCTTCATCTACACCCTTTACAG 134
HSPB1 NM_205290 CTGGTGGTGAAGACTAAGGATAAC GGGTGTATTTGCGGGTGAAG 106
MYLPF M11030.1 CCTCCAATGTCTTCTCTATG TCCAACTCCTCGTTCTTC 160
TRIM27.2 NM_001099359 GCAAGCACTGAAGGAAGAC AGCCAGCAGGTGATGTTC 166
EXFABP NM_205422 GCTGGACACGGACTACAAGAG GCTCACCTCACGGCTTCTG 106
GAPDH AF047874 GTGAAGGCTGCTGCTGATG AGGTGGAGGAATGGCTGTC 100
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Page 15 of 17Additional material
Additional file 1: Additional_file_1.doc containing the MALDI-TOF
spectrum and MALDI-TOF-TOF spectrum of differentially expressed
protein spots in IBV-infected chicken embryo tracheal tissues.
Additional file 2: Additional_file_2.doc containing the PMF
spectrum and Mascot database search results of differentially
expressed protein spots in IBV-infected chicken embryo tracheal
tissues.
Additional file 3: Additional_file_3.doc containing the MALDI-TOF
spectrum and MALDI-TOF-TOF spectrum of differentially expressed
protein spots in IBV-infected chicken embryo kidney tissues.
Additional file 4: Additional_file_4.doc containing the PMF
spectrum and Mascot database search results of differentially
expressed protein spots in IBV-infected chicken embryo kidney
tissues.
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ACN: acetonitrile; CHAPS: 3-[(3-cholamidopropyl) dimethyl-ammonio] -1-
propanesulfonate; DTT: dithiothreitol; GAPDH: glyceraldehyde-3-phosphate
dehydrogenase; IBV: Infectious bronchitis coronavirus; IEF: isoelectric
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two-dimensional gel electrophoresis.
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